These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31641861)

  • 21. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
    Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
    Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
    Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M
    J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
    Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
    J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local control and overall survival in atypical meningioma: a retrospective study.
    Goyal LK; Suh JH; Mohan DS; Prayson RA; Lee J; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):57-61. PubMed ID: 10656373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supervised machine learning algorithms demonstrate proliferation index correlates with long-term recurrence after complete resection of WHO grade I meningioma.
    Nguyen MP; Morshed RA; Dalle Ore CL; Cummins DD; Saggi S; Chen WC; Choudhury A; Ravi A; Raleigh DR; Magill ST; McDermott MW; Theodosopoulos PV
    J Neurosurg; 2023 Jan; 138(1):86-94. PubMed ID: 36303473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
    Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
    J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.
    Prat-Acín R; Guarín-Corredor MJ; Galeano-Senabre I; Ayuso-Sacido A; Vera-Sempere F
    J Clin Neurosci; 2021 Apr; 86():32-37. PubMed ID: 33775343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of radiotherapy following gross-total resection of atypical meningiomas.
    Komotar RJ; Iorgulescu JB; Raper DM; Holland EC; Beal K; Bilsky MH; Brennan CW; Tabar V; Sherman JH; Yamada Y; Gutin PH
    J Neurosurg; 2012 Oct; 117(4):679-86. PubMed ID: 22920955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. World Health Organization Grade II Meningioma: A 10-Year Retrospective Study for Recurrence and Prognostic Factor Assessment.
    Champeaux C; Dunn L
    World Neurosurg; 2016 May; 89():180-6. PubMed ID: 26850975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression-Free Survival and Factors Associated with Postoperative Recurrence in 126 Patients with Atypical Intracranial Meningioma.
    Phonwijit L; Khawprapa C; Sitthinamsuwan B
    World Neurosurg; 2017 Nov; 107():698-705. PubMed ID: 28838877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proposed Treatment for Intracranial Transitional Meningioma: A Single-Center Series of 298 Cases.
    Ma XJ; Zhang GJ; Wang W; Li D; Wu Z; Zhang JT
    World Neurosurg; 2019 Jul; 127():e280-e287. PubMed ID: 30902770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting post-operative recurrence or growth of meningiomas, other than histological grade and extent of resection.
    Quddusi A; Virani QU; Shamim MS
    J Pak Med Assoc; 2019 Oct; 69(10):1570-1571. PubMed ID: 31622321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early adjuvant radiotherapy in the treatment of atypical meningioma.
    Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
    J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical Meningiomas: Recurrence, Reoperation, and Radiotherapy.
    Klinger DR; Flores BC; Lewis JJ; Hatanpaa K; Choe K; Mickey B; Barnett S
    World Neurosurg; 2015 Sep; 84(3):839-45. PubMed ID: 25916182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series.
    Pessina F; Navarria P; Clerici E; Soffietti R; Nibali MC; Rudà R; Riva M; Scorsetti M; Bello L
    World Neurosurg; 2019 Mar; 123():e273-e279. PubMed ID: 30496926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.
    Wang C; Kaprealian TB; Suh JH; Kubicky CD; Ciporen JN; Chen Y; Jaboin JJ
    Neuro Oncol; 2017 Sep; 19(9):1263-1270. PubMed ID: 28371851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
    Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas.
    Tao X; Dong J; Hou Z; Hao S; Zhang J; Wu Z; Liu B
    World Neurosurg; 2018 Mar; 111():e880-e887. PubMed ID: 29325940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival and Prognostic Predictors of Anaplastic Meningiomas.
    Masalha W; Heiland DH; Delev D; Fennell JT; Franco P; Scheiwe C; Mercas BI; Mader I; Schnell O; Grauvogel J
    World Neurosurg; 2019 Nov; 131():e321-e328. PubMed ID: 31356972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.